HAWK Biosystems is a bio-imaging company developing QF-Pro®, a spatial biology platform for quantifying functional proteomic events directly in cells and fixed tissue samples. Using a proprietary FRET-based approach, QF-Pro® measures protein?protein interactions and post-translational modifications, providing functional information beyond conventional protein-expression analysis. The dedicated Violet 3.0 imaging platform and QF-Pro® software integrate sample scanning, ROI mapping, automated acquisition and analysis, QF-Pro® score generation, image processing, and data export. This workflow supports immuno-oncology, tumour microenvironment, biomarker, translational, and clinical research by enabling researchers to evaluate protein function and molecular interactions in their spatial context.